Literature DB >> 3110348

Genotypic analysis of B cell colonies by in situ hybridization. Stoichiometric expression of three VH families in adult C57BL/6 and BALB/c mice.

D H Schulze, G Kelsoe.   

Abstract

The filter paper disc method for cloning inducible lymphocytes was used to census the splenic B cell population of C57BL/6 and BALB/c mice for the expression of three VH gene-families, VH X-24, -Q52, and -J558. B cell colonies, arising from single founder lymphocytes, were identified by in situ hybridization with VH family- and C mu-specific cDNA probes. Some 6.7 X 10(4) C mu+ colonies were screened. Among C57BL/6- or BALB/c-derived colonies, approximately 3% were VH X-24+, approximately 19% were VH Q52+, and approximately 54% were VH J558+. These frequencies are consistent with a process of equiprobable expression for individual VH segments, and provide direct evidence that normal splenic B lymphocytes use a process of random genetic combinatorics to generate the antibody repertoire.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110348      PMCID: PMC2188642          DOI: 10.1084/jem.166.1.163

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Cloning of mitogen- and antigen-reactive B lymphocytes on filter paper discs. I. A description of the technique and of methods for the analysis of colonies.

Authors:  G Kelsoe
Journal:  J Immunol Methods       Date:  1985-02-11       Impact factor: 2.303

3.  One heavy chain variable region gene segment subfamily in the BALB/c mouse contains 500-1000 or more members.

Authors:  D Livant; C Blatt; L Hood
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

4.  Developmentally controlled expression of immunoglobulin VH genes.

Authors:  R M Perlmutter; J F Kearney; S P Chang; L E Hood
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

5.  Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte.

Authors:  J Andersson; A Coutinho; W Lernhardt; F Melchers
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

6.  Cloning of mitogen- and antigen-reactive B lymphocytes on filter paper discs. II. Paratope frequencies within the mitogen-selected repertoire.

Authors:  G Kelsoe; J T Stout
Journal:  Cell Immunol       Date:  1986-04-01       Impact factor: 4.868

7.  Influence of clonal selection on the expression of immunoglobulin variable region genes.

Authors:  T Manser; S Y Huang; M L Gefter
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

8.  VH-gene expression in murine lipopolysaccharide blasts distributes over the nine known VH-gene groups and may be random.

Authors:  R Dildrop; U Krawinkel; E Winter; K Rajewsky
Journal:  Eur J Immunol       Date:  1985-11       Impact factor: 5.532

9.  VH genes encoding the immune response to beta-(1,6)-galactan: somatic mutation in IgM molecules.

Authors:  A B Hartman; S Rudikoff
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

10.  Frequencies of mitogen-reactive B cells in the mouse. I. Distribution in different lymphoid organs from different inbred strains of mice at different ages.

Authors:  J Andersson; A Coutinho; F Melchers
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

View more
  23 in total

Review 1.  Pairing of VK and VK gene families in self-reactive antibodies.

Authors:  C A Bona; Y Saitoh; G Kelsoe
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

2.  Stochastic pairing of heavy-chain and kappa light-chain variable gene families occurs in polyclonally activated B cells.

Authors:  A Kaushik; D H Schulze; F A Bonilla; C Bona; G Kelsoe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

3.  Analysis of the expression immunoglobulin gene repertoire by screening libraries derived from PCR-amplified cDNA.

Authors:  K N Kasturi; C A Bona
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

4.  Mapping of antibody specificities to VH gene families.

Authors:  G Kelsoe; R Miceli; J Cerny; D H Schulze
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation.

Authors:  H Ikematsu; N Harindranath; Y Ueki; A L Notkins; P Casali
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

6.  Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.

Authors:  H Kiyoi; T Naoe; K Horibe; R Ohno
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

7.  The genomic organization of immunoglobulin VH genes in Xenopus laevis shows evidence for interspersion of families.

Authors:  R N Haire; Y Ohta; R T Litman; C T Amemiya; G W Litman
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

8.  Chromosomal position of rearranging gene segments influences allelic exclusion in transgenic mice.

Authors:  T E Costa; H Suh; M C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Molecular cloning of the primary IgH repertoire: a quantitative analysis of VH gene usage in adult mice.

Authors:  K M Sheehan; P H Brodeur
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

10.  Sequence of the spacer in the recombination signal sequence affects V(D)J rearrangement frequency and correlates with nonrandom Vkappa usage in vivo.

Authors:  B Nadel; A Tang; G Escuro; G Lugo; A J Feeney
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.